A Phase Ib/II Study of Trovocabtagene Autoleucel (C-CAR088), an Anti-BCMA CAR T-Cell Therapy in Relapsed or Refractory Multiple Myeloma

被引：0
|
作者：
An, Gang [1 ]
Xu, Yan [1 ]
Yi, Shuhua [1 ]
Lyu, Rui [1 ]
Huang, Jiaqi [2 ]
Li, Wensi [2 ]
Zhang, Yiran [2 ]
Lan, Liping [2 ]
Qiu, Lugui [1 ]
机构：
[1] Chinese Acad Med Sci & Peking Union Med Coll, Inst Hematol & Blood Dis Hosp, Natl Clin Res Ctr Blood Dis, State Key Lab Expt Hematol,Haihe Lab Cell Ecosyst, Tianjin, Peoples R China
[2] Shanghai AbelZeta Ltd, Shanghai, Peoples R China
来源：
BLOOD | 2024年 / 144卷
关键词：
D O I：
10.1182/blood-2024-194774
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：7235 / 7236
页数：2
相关论文
共 50 条
  • [31] ANTI-BCMA CAR T-CELL THERAPY IN PATIENTS WITH REFRACTORY MYASTHENIA GRAVIS
    Tian, Dai-Shi
    Qin, Chuan
    Dong, Ming-Hao
    Heming, Michael
    Zhou, Luo-Qi
    Wang, Wen
    Cai, Song-Bai
    Li, Chun-Rui
    Wang, Di
    Zhang, Min
    Bu, Bitao
    zu Hoerste, Gerd Meyer
    Wang, Wei
    MUSCLE & NERVE, 2024, 70 (03) : 642 - 642
  • [32] COST-EFFECTIVENESS OF ANTI-BCMA CAR T-CELL THERAPY IN TRIPLE-CLASS REFRACTORY MULTIPLE MYELOMA
    Barnes, J., I
    Frosch, Z. A.
    Garfall, A. L.
    Vogl, D.
    Lin, J.
    VALUE IN HEALTH, 2022, 25 (07) : S343 - S343
  • [33] CAR T-cell therapy for relapsed or refractory multiple myeloma
    Stirrups, Robert
    LANCET ONCOLOGY, 2019, 20 (06): : E297 - E297
  • [34] CAR plus T-Cell Lymphoma Post Ciltacabtagene Autoleucel Therapy for Relapsed Refractory Multiple Myeloma
    Harrison, Simon J.
    Nguyen, Tamia
    Rahman, Marzia
    Er, Jeremy
    Li, Jessica
    Li, Katherine
    Lendvai, Nikoletta
    Schecter, Jordan M.
    Banerjee, Arnob
    Roccia, Tito
    Foulk, Brad
    Gu, Junchen
    Zhao, Hao
    Smirnov, Denis
    Slaughter, Ana
    Lonardi, Carolina
    Lee, Erin
    Marquez, Loreta
    Jadidi, Shirin
    Costa Filho, Octavio
    Patel, Nitin
    Geng, Dong
    Haynes, Nicole M.
    Kelly, Hannah
    Lade, Stephen
    Grimmond, Sean
    Blombery, Piers
    BLOOD, 2023, 142
  • [35] bb2121 anti-BCMA CAR T-cell therapy in patients with relapsed/refractory multiple myeloma: Updated results from a multicenter phase I study.
    Raje, Noopur S.
    Berdeja, Jesus G.
    Lin, Yi
    Munshi, Nikhil C.
    Samuel, David
    Siegel, DiCapua
    Liedtke, Michaela
    Jagannath, Sundar
    Madduri, Deepu
    Rosenblatt, Jacalyn
    Maus, Marcela Valderrama
    Turka, Ashley
    Lam, Lyh Ping
    Morgan, Richard A.
    Quigley, Travis
    Massaro, Monica
    Hege, Kristen
    Petrocca, Fabio
    Kochenderfer, James
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [36] A phase 1, multicenter study evaluating the safety and efficacy of KITE-585, an autologous anti-BCMA CAR T-cell therapy, in patients with relapsed/refractory multiple myeloma
    Cornell, Robert F.
    Bishop, Michael R.
    Kumar, Shaji
    Giralt, Sergio A.
    Nooka, Ajay K.
    Larson, Sarah M.
    Locke, Frederick L.
    Raje, Noopur S.
    Lei, Lei
    Dong, Jinghui
    Gall, John B. Le
    Rossi, John M.
    Orlowski, Robert Z.
    AMERICAN JOURNAL OF CANCER RESEARCH, 2021, 11 (06): : 3285 - 3293
  • [37] Biallelic Loss of BCMA Triggers Resistance to Anti-BCMA CAR T Cell Therapy in Multiple Myeloma
    Samur, Mehmet K.
    Fulciniti, Mariateresa
    Aktas-Samur, Anil
    Bazarbachi, Abdul Hamid
    Tai, Yu-Tzu
    Campbell, Timothy B.
    Petrocca, Fabio
    Hege, Kristen
    Kaiser, Shari
    Anderson, Kenneth
    Munshi, Nikhil C.
    BLOOD, 2020, 136
  • [38] Real world single center expeirence of long-term toxicities with anti-BCMA CAR T-cell therapy in relapsed and refractory multiple myeloma
    Costello, Patrick
    Laubach, Jacob
    Mo, Clifton
    Sperling, Adam
    Nikiforow, Sarah
    Redd, Robert
    Ramsdell, Linda
    Finn, Kathleen
    Desnoyers, Lauren
    Denisco, Michelle
    Fraser, Esther
    Bianchi, Giada
    Hartley-Brown, Monique
    Ghobrial, Irene
    Richardson, Paul
    Anderson, Kenneth
    Munshi, Nikhil
    Nadeem, Omar
    Midha, Shonali
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S54 - S54
  • [39] Infectious complications in patients with relapsed refractory multiple myeloma after BCMA CAR T-cell therapy
    Kambhampati, Swetha
    Sheng, Ying
    Huang, Chiung-Yu
    Bylsma, Sophia
    Lo, Mimi
    Kennedy, Vanessa
    Natsuhara, Kelsey
    Martin, Thomas
    Wolf, Jeffrey
    Shah, Nina
    Wong, Sandy W.
    BLOOD ADVANCES, 2022, 6 (07) : 2045 - 2054
  • [40] Phase II Study of Pembrolizumab in Multiple Myeloma Patients Relapsing after or Refractory to Anti-BCMA CAR-T Therapies
    Chung, Alfred
    Huang, Chiung-Yu
    Martin, Thomas
    Wolf, Jeffrey L.
    Wong, Sandy W.
    Shah, Nina
    BLOOD, 2022, 140 : 12651 - 12652
12345